Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - NET CHANGE IN CASH
Net Change in Cash APLS - Apellis Pharmaceuticals, Inc.
-201 M
LAST VALUE
-92.03%
2 YEAR CAGR
-217.51%
5 YEAR CAGR
-49.30%
10 YEAR CAGR